検索結果 - Valentina Robustelli
- 検索結果 1 - 3 結果 / 3
-
1
Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia 著者: Andrea Ghelli Luserna di Rorà, Ilaria Iacobucci, Enrica Imbrogno, Cristina Papayannidis, Enrico Derenzini, Anna Ferrari, Viviana Guadagnuolo, Valentina Robustelli, Sarah Parisi, Chiara Sartor, Maria Chiara Abbenante, Stefania Paolini, Giovanni Martinelli
出版事項 2016Artigo -
2
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia 著者: Andrea Ghelli Luserna di Rorà, Neil Beeharry, Enrica Imbrogno, Anna Ferrari, Valentina Robustelli, Simona Righi, Elena Sabattini, Maria Vittoria Verga Falzacappa, Chiara Ronchini, Nicoletta Testoni, Carmen Baldazzi, Cristina Papayannidis, Maria Chiara Abbenante, Giovanni Marconi, Stefania Paolini, Sarah Parisi, Chiara Sartor, Maria Chiara Fontana, Sara De Matteis, Ilaria Iacobucci, Pier Giuseppe Pelicci, Michèle Cavo, Tim J. Yen, Giovanni Martinelli
出版事項 2018Artigo -
3
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemia 著者: Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Valentina Robustelli, Simona Soverini, Carolina Terragna, Giovanni Marconi, Roberto M. Lemoli, Fabio Guolo, Antonella Fornaro, Monia Lunghi, Paolo de Fabritiis, Anna Candoni, Carmine Selleri, Federico Simonetti, Monica Bocchia, Antonella Vitale, Luca Frison, Alessandra Tedeschi, Antonio Cuneo, Massimiliano Bonifacio, Maria Paola Martelli, Stefano D’Ardìa, Silvia Trappolini, Patrizia Tosi, Piero Galieni, Francesco Fabbiano, Maria Chiara Abbenante, Muriel Granier, Zhaoyin Zhu, Mingyue Wang, Chiara Sartor, Stefania Paolini, Michèle Cavo, Robin Foà, Paola Fazi, Marco Vignetti, Michele Baccarani
出版事項 2021Artigo
関連主題
Leukemia
Medicine
Cancer research
Dasatinib
Imatinib
Internal medicine
Lymphoblastic Leukemia
Myeloid leukemia
Acute lymphocytic leukemia
Adverse effect
Apoptosis
Biochemistry
Biology
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Clofarabine
Cytarabine
Gastroenterology
Genetics
Hematology
Imatinib mesylate
Immunology
Intensive care medicine
Oncology
Pharmacology
Ponatinib
Prednisone
Progenitor cell